Back to results
US 2014/0228417 A1Published application
Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids
AssigneeMapi Pharma Ltd.
InventorsMichael Mizhiritskii, Ehud Marom, Shai Rubnov
Life of this patent
Estimating the term…
Abstract
The present invention relates to processes and intermediates for the preparation of derivatives of 2-arylthiazole such as Febuxostat and its analogs. Febuxostat which is an inhibitor of xanthine oxidase, is used for the treatment of chronic hyperuricaemia in conditions in which urate deposition has occurred, such as gouty arthritis.
Claims24
1-23. (canceled)
A process for the preparation of Febuxostat represented by the structure of formula (1):
- the process comprising the steps of:
- (a) coupling a thiazole carboxylic acid derivative of formula (III):
- with an aryl derivative of formula (II)
- to form a 2-arylthiazolcarboxylic acid derivative of formula (IV):
- wherein
- R1 is methyl and R2 is isobutyl;
- R is H or Si(Ra)3 wherein each Ra is independently of the other an unsubstituted or substituted alkyl, arylalkyl or aryl;
- X, Y and Z are as described in (i) or (ii) hereinbelow:
- (i) X is Hal or OSO2R′ wherein R′ is an unsubstituted or substituted alkyl, alkylaryl or aryl, Z is absent and Y is B(OR″)2 wherein R″ is H or an unsubstituted or substituted alkyl or aryl;
- or
- (ii) X is absent, Z together with the nitrogen to which is attached forms an N-oxide moiety of the formula ⊕N—O⊖;
- and Y is Hal or OSO2R′ wherein R′ is as defined above;
- (b) when Z together with the nitrogen to which is attached forms an N-oxide, reducing the compound of formula (IV);
- and
- (c) optionally, when R is Si(Ra)3, converting the resultant compound of step (a) or (b) to Febuxostat of formula (1).
12 more elements
Dependencies are inferred from the claim text.